Estradiol regulates different genes in human breast tumor xenografts compared with the identical cells in culture

Endocrinology

Volumn 147, Issue 2, 2006, Pages 700-713

  Harvell, Djuana M E ^a   Richer, Jennifer K ^a   Allred, D Craig ^b   Sartorius, Carol A ^a   Horwitz, Kathryn B ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; TAMOXIFEN;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CONTROLLED STUDY; GENE CONTROL; HORMONE RESISTANCE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MICROENVIRONMENT; NUCLEOTIDE SEQUENCE; OVARIECTOMY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE; XENOGRAFT;

ANALYSIS OF VARIANCE; ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CELL LINE, TUMOR; ESTRADIOL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, NUDE; NEOPLASM PROTEINS; RECEPTORS, ESTROGEN; TAMOXIFEN; TRANSPLANTATION, HETEROLOGOUS;

EID: 30944454492     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2005-0617     Document Type: Article

References (77)

1. Clark GM, Osborne CK, McGuire WL 1984 Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer. J Clin Oncol 2:1102-1109
2. Charpentier AH, Bednarek AK, Daniel RL, Hawkins KA, Laflin KJ, Gaddis S, MacLeod MC, Aldaz CM 2000 Effects of estrogen on global gene expression: identification of novel targets of estrogen action. Cancer Res 60:5977-5983
3. Soulez M, Parker MG 2001 Identification of novel oestrogen receptor target genes in human ZR75-1 breast cancer cells by expression profiling. J Mol Endocrinol 27:259-274
4. Inoue A, Yoshida N, Omoto Y, Oguchi S, Yamori T, Kiyama R, Hayashi S 2002 Development of cDNA microarray for expression profiling of estrogen-responsive genes. J Mol Endocrinol 29:175-192
5. Lobenhofer EK, Bennett L, Cable PL, Li L, Bushel PR, Afshari CA 2002 Regulation of DNA replication fork genes by 17β-estradiol. Mol Endocrinol 16:1215-1229
6. Pedram A, Razandi M, Aitkenhead M, Hughes CC, Levin ER 2002 Integration of the non-genomic and genomic actions of estrogen. Membrane-initiated signaling by steroid to transcription and cell biology. J Biol Chem 277:50768-50775
7. Frasor J, Danes JM, Komm B,Chang KCN, Lyttle CR, Katzenellenbogen BS 2003 Profiling of estrogen up-and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144:4562-4574
8. Cicatiello L, Scafoglio C, Altucci L, Cancemi M, Natoli G, Facchiano A, Iazzetti G, Calogero R, Biglia N, DeBortoli M, Sfiligoi C, Sismondi P, Bresciani F, Weisz A 2004 A genomic view of estrogen actions in human breast cancer cells by expression profiling of the hormone-responsive transcriptome. J Mol Endocrinol 32:719-775
9. Frasor J, Stossi F, Danes JM, Komm B, Lyttle CR, Katzenellengoben BS 2004 selective estrogen receptor modulators: discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells. Cancer Res 64:1522-1533
10. Lin CY, Strom A, Vega VB, Kong SL, Yeo AL, Thomsen JS, Chan WC, Doray B, Bangarusamy DK, Ramasamy A, Vergara LA, Tang S, Chong A, Bajic VB, Miller LD, Gustafsson JA, Liu ET 2004 Discovery of estrogen receptor alpha target genes and response elements in breast tumor cells. Genome Biol 5:R66
11. Stossi F, Barnett DH, Frasor J, Komm B, Lyttle CR, Katzenellenbogen BS 2004 Transcriptional profiling of estrogen-regulated gene expression via estrogen receptor (ER) alpha or ERbeta in human osteosarcoma cells: distinct and common target genes for these receptors. Endocrinology 145:3473-3486
12. Wang DY, Fulthorpe R, Liss SN, Edwards EA 2004 Identification of estrogenresponsive genes by complementary deoxyribonucleic acid microarray and characterization of a novel early estrogen-induced gene: EEIG1. Mol Endocrinol 18:402-411
13. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH 2002 Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530-536
14. West M, Blanchette C, Dressman H, Huang E, Ishida S, Spang R, Zuzan H, Olson Jr JA, Marks JR, Nevins JR 2001 Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci USA 98:11462-11467
15. Dressman MA, Walz TM, Lavedan C, Barnes L, Buchholtz S, Kwon I, Ellis MJ, Polymeropoulos MH 2001 Genes that co-cluster with estrogen receptor alpha in microarray analysis of breast biopsies. Pharmacogenomics J 1:135-141
16. Kun Y, How LC, Hoon TP, Bajic VB, Lam TS, Aggarwal A, Sze HG, Bok WS, Yin WC, Tan P 2003 Classifying the estrogen receptor status of breast cancers by expression profiles reveals a poor prognosis subpopulation exhibiting high expression of the ERBB2 receptor. Hum Mol Genet 12:3245-3258
17. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R 2002 A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999-2009
18. Bertucci F, Houlgatte R, Benziane A, Granjeaud S, Adelaide J, Tagett R, Loriod B, Jacquemier J, Viens P, Jordan B, Birnbaum D, Nguyen C 2000 Gene expression profiling of primary breast carcinomas using arrays of candidate genes. Hum Mol Genet 9:2981-2991
19. Bertucci F, Nasser V, Granjeaud S, Eisinger F, Adelaide J, Tagett R, Loriod B, Giaconia A, Benziane A, Devilard E, Jacquemier J, Viens P, Nguyen C, Birnbaum D, Houlgatte R 2002 Gene expression profiles of poor-prognosis primary breast cancer correlate with survival. Hum Mol Genet 11:863-872
20. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D 2000 Molecular portraits of human breast tumours. Nature 406:747-752
21. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lonning P, Borresen-Dale AL 2001 Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869-10874
22. Weisz A, Basile W, Scafoglio C, Altucci L, Bresciani F, Facchiano A, Sismondi P, Cicatiello L, De Bortoli M 2004 Molecular identification of ERalpha-positive breast cancer cells by the expression profile of an intrinsic set of estrogen regulated genes. J Cell Physiol 200:440-450
23. Sartorius CA, Shen T, Horwitz KB 2003 Progesterone receptors A and B differentially affect the growth of estrogen-dependent human breast tumor xenografts. Breast Cancer Res Treat 79:287-299
24. Detre S, Salter J, Barnes DM, Riddler S, Hills M, Johnston SR, Gillett C, A'Hern R, Dowsett M 1999 Time-related effects of estrogen withdrawal on proliferationand cell death-related events in MCF-7 xenografts. Int J Cancer 81:309-313
25. Sartorius CA, Groshong SD, Miller LA, Powell RL, Tung L, Takimoto GS, Horwitz KB 1994 New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP. Cancer Res 54:3868-3877
26. Horwitz KB, Mockus MB, Lessey BA 1982 Variant T47D human breast cancer cells with high progesterone-receptor levels despite estrogen and antiestrogen resistance. Cell 28:633-642
27. Sartorius CA, Harvell DME, Shen T, Horwitz KB 2005 Progestins initiate a luminal to myoepithelial switch in estrogen-dependent human breast tumors without altering growth. Cancer Res 65:9779-9788
28. Gallo D, Cantelmo F, Distefano M, Ferlini C, Zannoni GF, Riva A, Morazzoni P, Bombardelli E, Mancuso S, Scambia G 1999 Reproductive effects of dietary soy in female Wistar rats. Food Chem Toxicol 37:493-502
29. Harvey JM, Clark GM, Osborne CK, Allred DC 1999 Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 17:1474-1481
30. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G 2000 Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25:25-29
31. Haugen BR, Jensen DR, Sharma V, Pulawa LK, Hays WR, Krezel W, Chambon P, Eckel RH 2004 Retinoid X receptor γ-deficient mice have increased skeletal muscle lipoprotein lipase activity and less weight gain when fed a high-fat diet. Endocrinology 145:3679-3685
32. Ghosh MG, Thompson DA, Weigel RJ 2000 PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer. Cancer Res 60:6367-6375
33. Horwitz KB, McGuire WL 1980 Nuclear estrogen receptors. Effect of inhibitors on processing and steady state levels. J Biol Chem 255:9699-9705
34. Platet N, Cathiard AM, Gleizes M, Garcia M 2004 Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol 51:55-67
35. Walser TC, Fulton AM 2004 The role of chemokines in the biology and therapy of breast cancer. Breast Dis 20:137-143
36. Desruisseau S, Palmari J, Giusti C, Romain S, Martin PM, Berthois Y 2004 Clinical relevance of amphiregulin and VEGF in primary breast cancers. Int J Cancer 111:733-740
37. Bachelder RE, Wendt MA, Mercurio AM 2002 Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res 62:7203-7206
38. Visvader JE, Venter D, Hahm K, Santamaria M, Sum EY, O'Reilly L, White D, Williams R, Armes J, Lindeman GJ 2001 The LIM domain gene LMO4 inhibits differentiation of mammary epithelial cells in vitro and is overexpressed in breast cancer. Proc Natl Acad Sci USA 98:14452-14457
39. Muller C, Leutz A 2001 Chromatin remodeling in development and differentiation. Curr Opin Genet Dev 11:167-174
40. Nelson KG, Sakai Y, Eitzman B, Steed T, McLachlan J 1994 Exposure to diethylstilbestrol during a critical developmental period of the mouse reproductive tract leads to persistent induction of two estrogen-regulated genes. Cell Growth Differ 5:595-606
41. Paulsen M, Ferguson-Smith AC 2001 DNA methylation in genomic imprinting, development, and disease. J Pathol 195:97-110
42. Ginger MR, Gonzalez-Rimbau MF, Gay JP, Rosen JM 2001 Persistent changes in gene expression induced by estrogen and progesterone in the rat mammary gland. Mol Endocrinol 15:1993-2009
43. Pentecost BT, Song R, Luo M, DePasquale JA, Fasco MJ 2005 Upstream regions of the estrogen receptor alpha proximal promoter transcript regulate ER protein expression through a translational mechanism. Mol Cell Endocrinol 229:83-94
44. Allar MA, Wood TL 2004 Expression of the insulin-like growth factor binding proteins during postnatal development of the murine mammary gland. Endocrinology 145:2467-2477
45. Lei J, Wu C, Wang X, Wang H 2005 p38 MAPK-dependent and YY1-mediated chemokine receptors CCR5 and CXCR4 up-regulation in U937 cell line infected by Mycobacterium tuberculosis or Actinobacillus actinomycetemcomitans. Biochem Biophys Res Commun 329:610-615
46. Loureiro RM, Maharaj AS, Dankort D, Muller WJ, D'Amore PA 2005 ErbB2 overexpression in mammary cells upregulates VEGF through the core promoter. Biochem Biophys Res Commun 326:455-465
47. Mori T, Kim J, Yamano T, Takeuchi H, Huang S, Umetani N, Koyanagi K, Hoon DS 2005 Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells. Cancer Res 65:1800-1807
48. Read LD, Greene GL, Katzenellenbogen BS 1989 Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors. Mol Endocrinol 3:295-304
49. Richer JK, Lange CA, Wierman AM, Brooks KM, Tung L, Takimoto GS, Horwitz KB 1998 Progesterone receptor variants found in breast cells repress transcription by wild-type receptors. Breast Cancer Res Treat 48:231-241
50. Shupnik MA, Gordon MS, Chin WW 1989 Tissue-specific regulation of rat estrogen receptor mRNAs. Mol Endocrinol 3:660-665
51. Osborne CK, Shou J, Massarweh S, Schiff R 2005 Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer. Clin Cancer Res 11:865s-870s
52. Gadal F, Starzec A, Bozic C, Pillot-Brochet C, Malinge S, Ozanne V, Vicenzi J, Buffat L, Perret G, Iris F, Crepin M 2005 Integrative analysis of gene expression patterns predicts specific modulations of defined cell functions by estrogen and tamoxifen in MCF7 breast cancer cells. J Mol Endocrinol 34:61-75
53. Hayashi S 2004 Prediction of hormone sensitivity by DNA microassay. Biomed Pharmacother 58:1-9
54. Coser KR, Chesnes J, Hur J, Ray S, Isselbacher KJ, Shioda T 2003 Global analysis of ligand sensitivity of estrogen inducible and suppressible genes in MCF7/BUS breast cancer cells by DNA microarray. Proc Natl Acad Sci USA 100:13994-13999
55. Omoto Y, Hayashi S 2002 A study of estrogen signaling using DNA microarray in human breast cancer. Breast Cancer 9:308-311
56. Singleton DW, Feng Y, Chen Y, Busch SJ, Lee AV, Puga A, Khan SA 2004 Bisphenol-A and estradiol exert novel gene regulation in human MCF-7 derived breast cancer cells. Mol Cell Endocrinol 221:47-55
57. Kuang WW, Thompson DA, Hoch RV, Weigel RJ 1998 Differential screening and suppression subtractive hybridization identified genes differentially expressed in an estrogen receptor-positive breast carcinoma cell line. Nucleic Acids Res 26:1116-1123
58. Levenson AS, Svoboda KM, Pease KM, Kaiser SA, Chen B, Simons LA, Jovanovic BD, Dyck PA, Jordan VC 2002 Gene expression profiles with activation of the estrogen receptor alpha-selective estrogen receptor modulator complex in breast cancer cells expressing wild-type estrogen receptor. Cancer Res 62:4419-4426
59. Montano MM, Katzenellenbogen BS 1997 The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens. Proc Natl Acad Sci USA 94:2581-2586
60. Hall JM, Korach KS 2002 Analysis of the molecular mechanisms of human estrogen receptors alpha and beta reveals differential specificity in target promoter regulation by xenoestrogens. J Biol Chem 277:44455-44461
61. Inadera H, Hashimoto S, Dong HY, Suzuki T, Nagai S, Yamashita T, Toyoda N, Matsushima K 2000 WISP-2 as a novel estrogen-responsive gene in human breast cancer cells. Biochem Biophys Res Commun 275:108-114
62. Ein-Dor L, Kela I, Getz G, Givol D, Domany E 2005 Outcome signature genes in breast cancer: is there a unique set? Bioinformatics 21:171-178
63. Beck CA, Weigel NL, Moyer ML, Nordeen SK, Edwards DP 1993 The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways. Proc Natl Acad Sci USA 90:4441-4445
64. Gruvberger S, Ringner M, Chen Y, Panavally S, Saal LH, Borg A, Ferno M, Peterson C, Meltzer PS 2001 Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res 61:5979-5984
65. Nagahata T, Onda M, Emi M, Nagai H, Tsumagari K, Fujimoto T, Hirano A, Sato T, Nishikawa K, Akiyama F, Sakamoto G, Kasumi F, Miki Y, Tanaka T, Tsunoda T 2004 Expression profiling to predict postoperative prognosis for estrogen receptor-negative breast cancers by analysis of 25,344 genes on a cDNA microarray. Cancer Sci 95:218-225
66. Nagai MA, Da Ros N, Neto MM, de Faria Junior SR, Brentani MM, Hirata Jr R, Neves EJ 2004 Gene expression profiles in breast tumors regarding the presence or absence of estrogen and progesterone receptors. Int J Cancer 111:892-899
67. Hunt SM, Clarke CL 1999 Expression and hormonal regulation of the Sox4 gene in mouse female reproductive tissues. Biol Reprod 61:476-481
68. Bouras T, Southey MC, Chang AC, Reddel RR, Willhite D, Glynne R, Henderson MA, Armes JE, Venter DJ 2002 Stanniocalcin 2 is an estrogen-responsive gene coexpressed with the estrogen receptor in human breast cancer. Cancer Res 62:1289-1295
69. Martinez-Lacaci I, Saceda M, Plowman GD, Johnson GR, Normanno N, Salomon DS, Dickson RB 1995 Estrogen and phorbol esters regulate amphiregulin expression by two separate mechanisms in human breast cancer cell lines. Endocrinology 136:3983-3992
70. Watanabe H, Suzuki A, Kobayashi M, Takahashi E, Itamoto M, Lubahn DB, Handa H, Iguchi T 2003 Analysis of temporal changes in the expression of estrogen-regulated genes in the uterus. J Mol Endocrinol 30:347-358
71. Simard J, de Launoit Y, Haagensen DE, Labrie F 1992 Additive stimulatory action of glucocorticoids and androgens on basal and estrogen-repressed apolipoprotein-D messenger ribonucleic acid levels and secretion in human breast cancer cells. Endocrinology 130:1115-1121
72. Mitev YA, Wolf SS, Almeida OF, Patchev VK 2003 Developmental expression profiles and distinct regional estrogen responsiveness suggest a novel role for the steroid receptor coactivator SRC-1 as discriminative amplifier of estrogen signaling in the rat brain. FASEB J 17:518-519
73. Robertson JA, Farnell Y, Lindahl LS, Ing NH 2002 Estradiol up-regulates estrogen receptor messenger ribonucleic acid in endometrial carcinoma (Ishikawa) cells by stabilizing the message. J Mol Endocrinol 29:125-135
74. Henttu P, Liao SS, Vihko P 1992 Androgens up-regulate the human prostatespecific antigen messenger ribonucleic acid (mRNA), but down-regulate the prostatic acid phosphatase mRNA in the LNCaP cell line. Endocrinology 130:766-772
75. Stoner M, Wormke M, Saville B, Samudio I, Qin C, Abdelrahim M, Safe S 2004 Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor α and SP proteins. Oncogene 23:1052-1063
76. Reese J, Das SK, Paria BC, Lim H, Song H, Matsumoto H, Knudtson KL, DuBois RN, Dey SK 2001 Global gene expression analysis to identify molecular markers of uterine receptivity and embryo implantation. J Biol Chem 276:44137-44145
77. Islamov RR, Hendricks WA, Katwa LC, McMurray RJ, Pak ES, Spanier NS, Murashov AK 2003 Effect of 17β-estradiol on gene expression in lumbar spinal cord after sciatic nerve crush injury in ovx mice. Brain Res 966:65-75